AMIVANTAMAB 50 MG/ML SOL INJ FR 7 ML IV
TED · 621066-2026Award notice · social & specific servicesawardedNo deadline given
Value
Estimated—
Awarded€394,934 · 394,934.4 EUR
WinnerJanssen - Cilag Farmacêutica Lda
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde de São José, EPE in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Vertex Pharmaceuticals (Portugal), Unipessoal Lda | 2 | €5,562,837 | 2026-08-07 |
| Roche Sistemas de Diagnósticos, Lda | 2 | €4,637,771 | 2026-08-04 |
| Novo Nordisk, Lda | 2 | €1,931,304 | 2026-08-17 |
| Johnson & Johnson, Lda. | 2 | €1,265,691 | 2026-07-06 |
| Stryker Portugal Produtos Médicos, Lda. | 2 | €869,259 | 2026-08-03 |
Full buyer profile: what Unidade Local de Saúde de São José, EPE buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
AMIVANTAMAB 50 MG/ML SOL INJ FR 7 ML IV